Literature DB >> 8567213

Report from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). Guidelines for economic evaluation of pharmaceuticals: Canada.

.   

Abstract

Mesh：

Year:  1995        PMID： 8567213     DOI： 10.1017/s0266462300009247

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN： 0266-4623            Impact factor:   2.188


× No keyword cloud information.
  47 in total

1.  Handling uncertainty in economic evaluations of healthcare interventions.

Authors:  A H Briggs; A M Gray
Journal:  BMJ       Date:  1999-09-04

2.  The revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals.

Authors:  J L Glennie; G W Torrance; J F Baladi; C Berka; E Hubbard; D Menon; N Otten; M Rivière
Journal:  Pharmacoeconomics       Date:  1999-05       Impact factor: 4.981

3.  Using economic evaluations to make formulary coverage decisions. So much for guidelines.

Authors:  A H Anis; Y Gagnon
Journal:  Pharmacoeconomics       Date:  2000-07       Impact factor: 4.981

4.  Reporting format for economic evaluation. Part II: Focus on modelling studies.

Authors:  M J Nuijten; M H Pronk; M J Brorens; Y A Hekster; J H Lockefeer; P A de Smet; G Bonsel; A van der Kuy
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

Review 5.  Reassessing the relevance of pharmacoeconomic analyses in formulary decisions.

Authors:  J A Johnson; E Friesen
Journal:  Pharmacoeconomics       Date:  1998-05       Impact factor: 4.981

Review 6.  The selection of data sources for use in modelling studies.

Authors:  M J Nuijten
Journal:  Pharmacoeconomics       Date:  1998-03       Impact factor: 4.981

7.  Measuring sensitivity in pharmacoeconomic studies. An integration of point-sensitivity and range-sensitivity.

Authors:  M J Nuijten; M Hardens
Journal:  Pharmacoeconomics       Date:  1997-11       Impact factor: 4.981

Review 8.  Health-related quality of life and regulatory issues in the US and Canada.

Authors:  Judith Glennie
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

9.  Standardisation of costs: the Dutch Manual for Costing in economic evaluations.

Authors:  Jan B Oostenbrink; Marc A Koopmanschap; Frans F H Rutten
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

10.  Integer/linear mathematical programming models: a tool for allocating healthcare resources.

Authors:  Stephanie R Earnshaw; Susan L Dennett
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.